- Home
- SMTI vs NYXH Comparison
SMTI vs NYXH Comparison
Compare SMTI & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- NYXH
- Stock Information
- Founded
- SMTI 1982
- NYXH 2009
- Country
- SMTI United States
- NYXH Belgium
- Employees
- SMTI N/A
- NYXH N/A
- Industry
- SMTI Medical/Dental Instruments
- NYXH Medical/Dental Instruments
- Sector
- SMTI Health Care
- NYXH Health Care
- Exchange
- SMTI Nasdaq
- NYXH Nasdaq
- Market Cap
- SMTI 273.6M
- NYXH 222.3M
- IPO Year
- SMTI N/A
- NYXH 2021
- Fundamental
- Price
- SMTI $28.88
- NYXH $7.71
- Analyst Decision
- SMTI Strong Buy
- NYXH Strong Buy
- Analyst Count
- SMTI 2
- NYXH 4
- Target Price
- SMTI $49.50
- NYXH $14.50
- AVG Volume (30 Days)
- SMTI 35.1K
- NYXH 135.0K
- Earning Date
- SMTI 05-14-2025
- NYXH 05-14-2025
- Dividend Yield
- SMTI N/A
- NYXH N/A
- EPS Growth
- SMTI N/A
- NYXH N/A
- EPS
- SMTI N/A
- NYXH N/A
- Revenue
- SMTI $91,569,883.00
- NYXH $4,716,818.00
- Revenue This Year
- SMTI $23.53
- NYXH $323.07
- Revenue Next Year
- SMTI $5.93
- NYXH $204.30
- P/E Ratio
- SMTI N/A
- NYXH N/A
- Revenue Growth
- SMTI 34.65
- NYXH N/A
- 52 Week Low
- SMTI $25.86
- NYXH $5.55
- 52 Week High
- SMTI $39.08
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- SMTI 39.00
- NYXH 59.14
- Support Level
- SMTI $28.50
- NYXH $7.52
- Resistance Level
- SMTI $29.82
- NYXH $8.00
- Average True Range (ATR)
- SMTI 0.95
- NYXH 0.51
- MACD
- SMTI -0.24
- NYXH 0.06
- Stochastic Oscillator
- SMTI 21.02
- NYXH 63.95
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.